Beacon Immune Tolerance Database Summary
- Unrivalled comprehensive & accurate preclinical and clinical Immune Tolerance drug, trial and commercial data.
- Access to 6,500+ Drugs, 13,000+ Trials, 6,100+ Companies, and 6,600+ Deals in the Immune Tolerance space
- Market leading ontologies, enabling precise navigation of specific Immune Tolerance therapies
- Manually curated by Immune Tolerance scientists, with data updated daily
- Your one stop shop for Immune Tolerance therapy intelligence data
Why Beacon Immune Tolerance Database?
Advanced Search Filtering
Drill down into Beacon’s Immune Tolerance drug and trial data with a unique selection of >30 search filters. Segment the Immune Tolerance drug and trial landscape to identify the data that matters most to you. Our filters include:
Drug Target
Drug Modality
Disease Indication
Autoantigen Specificity
Cell Source
Cell Type
Editing Technology
Delivery System
Drug Status
Drug & Trial Milestones
Trial Phase & Location
How Beacon Immune Tolerance Database Can Help You?
Give your therapeutic design the best chance of success for a given target/indication, by gaining a comprehensive overview into successful & failed strategies for the various therapeutic modalities being explored, narrowing down the landscape into niche areas of competition
Confidently benchmark your preclinical research by accessing the most extensive collection of preclinical data available.
Beacon brings together curated data—including in vitro, efficacy, toxicity, and pharmacokinetics (PK)—from every immune-mediated disease targeting program, all in one place. Our comprehensive preclinical data enables you to compare your readouts against the broader field, giving you the insights needed to guide and validate your research.
Track clinical developments through to approvals with a market leading curation approach, segmenting clinical readouts into drug dosing, patient data, toxicity & results, with 100s of conferences curated
Drastically reduce manual research time with our database solution which allows you to rapidly assemble data for analysis on targets, modalities and much more and evaluate the latest trends
Optimize your partnership strategy by identifying new prospect companies or competitors as soon as they enter the field, taking advantage of Beacon’s unique approach to capturing early-stage companies
Bulletproof your investment strategy by confidently communicating your position in the market to investors, with well benchmarked science, allowing you to stand out in a competitive market
Track & analyse the booming commercial market, with all financing & partnership deals tagged and curated in one place, allowing you to quickly understand the science & insights leading to major deals in the space, identify suitable partners & investors and maximise your own commercial opportunity in a blossoming market
Beacon Immune Tolerance Database: The Numbers
Beacon Immune Tolerance Database: Key Data Segments
Drug Data
Revolutionize your landscape searching for Immune Tolerance therapies.
Utilize >20 search filters to find programs based on disease indication, drug modality, autoantigen specificity, mechanism of action, delivery system and many more.
Trial Data
Optimize your Immune Tolerance clinical trial design searching capabilities.
Seamlessly benchmark clinical trial results and search the Immune Tolerance trial landscape based on drug technologies, combination trials, trial locations, trial phase, disease indication and more.
Milestones
A unique Immune Tolerance development milestone filter and visualization tool.
Track past, present, and future Immune Tolerance drug development milestones, including drug and trial readouts, asset history, and regulatory announcements.
Company Data
Your centralized location for Immune Tolerance company intelligence
Identify competitors and business development opportunities, using unique company filters including, company type, HQ locations, operating status & latest funding round, and technologies / diseases targeted in their pipeline.
Deal Data
De-risk your Immune Tolerance partnership & fundraising projects
Search Immune Tolerance deals using custom search filters based on drug technologies involved, deal value & upfront payments, deal types to filter M&As, financing & partnership / licensing deals, geographic market, funding type, and many more.
Beacon Immune Tolerance Database: Drug Modalities
Analyze 6,500+ drugs (preclinical and clinical) and 13,000+ clinical trials (from early to late stage).
Beacon Immune Tolerance covers all pharmaceutical interventions used to treat autoimmune diseases, autoinflammatory diseases, alloimmune diseases and allergies.
From small molecules to CAR T therapies, the module encapsulates all drugs and trials within the immune-mediated disease space.
Beacon Immune Tolerance also includes a host of preclinical data including, cell line and animal model experimental data.
Who is Beacon Immune Tolerance Database For?
Beacon Immune Tolerance is a manually curated database of comprehensive, high quality, and accurate, preclinical and clinical drug, trial and commercial data, offering unrivalled insight into the Immune Tolerance drug development landscape.
Scientific Strategy Leader
Select the right pipeline for your Immune Tolerance drug development
Research Scientist
Validate new targets & inform your Immune Tolerance design
Clinical Development
Design optimized Immune Tolerance clinical trials & benchmark against the competition
Business Development
Uncover new Immune Tolerance licensing, partnership and fundraising opportunities
Competitive Intelligence
Track competitive threats & emerging Immune Tolerance technologies
Translational Development
Confidently take your preclinical Immune Tolerance therapy into the clinic
Related Solutions
Check out additional solutions available from Beacon
Related Resources
Check out Immune Tolerance related resources available from Beacon
Our Experts
Bella Glover
Lead Research Analyst
Charlie De Lanoy Meijer
Account Manager
Frank Plowden
